TheEdgeResearch
Home / Stocks / PYVAX

Payden Equity Income Fund Adviser Cl (PYVAX)

NASDAQ Financial Services Asset Management - Income
$19.33 ▲ +0.26%
Market Cap
$1.37B
Sector
Financial Services
Industry
Asset Management - Income
Beta
0.78
52-Wk Range
16.61-19.33
CEO
Country
US
Currency
USD

Payden Equity Income Fund Adviser Cl operates in the Asset Management - Income industry of the Financial Services sector, headquartered in Los Angeles, CA, US. The stock last traded at $19.33, up 0.26% on the session, giving a market capitalisation of $1.37B. On trailing twelve-month figures it carries a trailing P/E of 6.98, a net margin of 1213.7%. Its beta of 0.78 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
6.98
Price / Sales
149.24
Price / Book
0.00
EV / EBITDA
12.54
Gross margin
100.0%
Operating margin
23.8%
Net margin
1213.7%
Return on equity
Debt / equity
0.00
Current ratio
0.73
Dividend yield
5.5%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
IPO date
2011-12-01
Headquarters
Los Angeles, CA, US
About Payden Equity Income Fund Adviser Cl

The Payden Equity Income Fund endeavors to deliver both long-term capital appreciation and a consistent level of current income to its investors. Its investment strategy primarily centers on well-established, large-capitalization value stocks, identified by their substantial market value and tendency to offer above-average dividend yields. The fund also diversifies into other equity-related instruments that produce income, such as preferred shares, real estate investment trusts (REITs), and master limited partnerships (MLPs). While the majority of its holdings are in U.S. securities, the fund retains the option to allocate up to 30% of its total assets to international equities, including those from developing nations.

Comparable companies

Payden Equity Income Fund Adviser Cl is most often compared with the following Financial Services names:

ABCVXBMDIXBMDSXEOSFPFPACIXPYVSXRYTFXSSIRXSSIZX
More research on PYVAX
PYVAX technical analysis PYVAX TheEdge Score Compare against peers
Open full interactive analysis & DCF →